JP2016518420A5 - - Google Patents

Download PDF

Info

Publication number
JP2016518420A5
JP2016518420A5 JP2016513304A JP2016513304A JP2016518420A5 JP 2016518420 A5 JP2016518420 A5 JP 2016518420A5 JP 2016513304 A JP2016513304 A JP 2016513304A JP 2016513304 A JP2016513304 A JP 2016513304A JP 2016518420 A5 JP2016518420 A5 JP 2016518420A5
Authority
JP
Japan
Prior art keywords
alkyl
group
cycloalkyl
heterocyclyl
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016513304A
Other languages
English (en)
Japanese (ja)
Other versions
JP6378752B2 (ja
JP2016518420A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/059537 external-priority patent/WO2014184104A1/en
Publication of JP2016518420A publication Critical patent/JP2016518420A/ja
Publication of JP2016518420A5 publication Critical patent/JP2016518420A5/ja
Application granted granted Critical
Publication of JP6378752B2 publication Critical patent/JP6378752B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016513304A 2013-05-17 2014-05-09 ピロリジン誘導体、その医薬組成物及び使用 Expired - Fee Related JP6378752B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13168294 2013-05-17
EP13168294.0 2013-05-17
PCT/EP2014/059537 WO2014184104A1 (en) 2013-05-17 2014-05-09 Pyrrolidine derivatives, pharmaceutical compositions and uses thereof

Publications (3)

Publication Number Publication Date
JP2016518420A JP2016518420A (ja) 2016-06-23
JP2016518420A5 true JP2016518420A5 (https=) 2017-06-22
JP6378752B2 JP6378752B2 (ja) 2018-08-22

Family

ID=48428386

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016513304A Expired - Fee Related JP6378752B2 (ja) 2013-05-17 2014-05-09 ピロリジン誘導体、その医薬組成物及び使用

Country Status (4)

Country Link
US (1) US9278954B2 (https=)
EP (1) EP2997024B1 (https=)
JP (1) JP6378752B2 (https=)
WO (1) WO2014184104A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3670496A3 (en) 2013-10-17 2020-09-30 Shionogi&Co., Ltd. Acc2 inhibitors
CN105861424B (zh) * 2016-04-27 2019-06-14 华东师范大学 一种大鼠体外受精营养液及其应用
WO2018027892A1 (en) * 2016-08-12 2018-02-15 Eli Lilly And Company Amino pyrimidine ssao inhibitors
WO2018148856A1 (en) 2017-02-14 2018-08-23 Eli Lilly And Company Diazaspirodecanyl-pyrimidine compounds useful as ssao inhibitors
JP2023539639A (ja) 2020-08-25 2023-09-15 イーライ リリー アンド カンパニー Ｓｓａｏ阻害剤の多形

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313127B1 (en) * 1996-02-02 2001-11-06 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
JP2009501733A (ja) 2005-07-20 2009-01-22 メルク フロスト カナダ リミテツド ステアロイルコエンザイムａデルタ−９デサチュラーゼの阻害剤としてのヘテロ芳香族化合物
AU2007252198A1 (en) 2006-05-22 2007-11-29 Merck Frosst Canada Ltd. Cyclic amine derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase
WO2007143824A1 (en) 2006-06-13 2007-12-21 Merck Frosst Canada Ltd. Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
JP2011500808A (ja) 2007-10-24 2011-01-06 メルク・シャープ・エンド・ドーム・コーポレイション 複素環アミドｔ型カルシウムチャネルアンタゴニスト
CN101910133A (zh) 2007-10-24 2010-12-08 默沙东公司 杂环苯基酰胺t-型钙通道拮抗剂
MX2010009204A (es) * 2008-02-22 2010-11-10 Irm Llc Compuestos y composiciones como modulares del a actividad de gpr119.
WO2009131196A1 (ja) * 2008-04-24 2009-10-29 武田薬品工業株式会社 置換ピロリジン誘導体およびその用途
GB0812648D0 (en) 2008-07-10 2008-08-20 Prosidion Ltd Compounds
FR2958935B1 (fr) * 2010-04-19 2012-06-22 Pf Medicament Derives d'heterocycles azotes, leur preparation et leur application en therapeutique humaine
US9006450B2 (en) * 2010-07-01 2015-04-14 Boehringer Ingelheim International Gmbh Compounds, pharmaceutical compositions and uses thereof
US8877754B2 (en) * 2010-09-06 2014-11-04 Boehringer Ingelheim International Gmbh Compounds, pharmaceutical compositions and uses thereof
US9169205B2 (en) * 2012-10-08 2015-10-27 Boehringer Ingelheim International Gmbh Pyrrolidine derivatives, pharmaceutical compositions and uses thereof

Similar Documents

Publication Publication Date Title
JP2016540742A5 (https=)
JP2016518420A5 (https=)
JP2015503622A5 (https=)
JP2017514910A5 (https=)
JP2016536364A5 (https=)
JP2015143283A5 (https=)
JP2017537940A5 (https=)
JP2015537020A5 (https=)
JP2019524883A5 (https=)
JP2016515560A5 (https=)
JP2009511490A5 (https=)
JP2017514830A5 (https=)
JP2013536235A5 (https=)
JP2016516699A5 (https=)
JP2018537413A5 (ja) 化合物、医薬的に許容される塩又はその立体異性体及び医薬組成物
JP2016536363A5 (https=)
JP2020502092A5 (https=)
BR112015022288B1 (pt) 2-aminopirimidin-6-onas e análogos exibindo atividades anticâncer e antiproliferativas, seus usos, e composição farmacêutica
JP2013509392A5 (https=)
JP2016519165A5 (https=)
JP2016501185A5 (https=)
JP2020527175A5 (https=)
JP2016531868A5 (https=)
JP2016531950A5 (ja) 複素環化合物
JP2018510138A5 (https=)